Described herein are pharmaceutical packaging methods which avert oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-delicate prescription drugs, these types of programs such as a syringe with an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with really very low permeabil